表紙
市場調查報告書

醫療部門3D列印:各主題調查

3D Printing in Healthcare - Thematic Research

出版商 GlobalData 商品編碼 939341
出版日期 內容資訊 英文 74 Pages
訂單完成後即時交付
價格
醫療部門3D列印:各主題調查 3D Printing in Healthcare - Thematic Research
出版日期: 2020年05月01日內容資訊: 英文 74 Pages
簡介

3D列印技術用於工業、電力、航太、汽車、消費者、醫療等,各種領域。在醫療部門中,再生醫療和組織工程使用的人體活細胞和組織,利用餘精密醫藥品、個體化醫藥品,義肢,整形外科及牙科用植入,外科器具,醫學教育模式等的醫療設備的製造等。人體組織和細胞的3D生物印刷,有可補充再生醫療,功能內臟器官置換,藥物研發等,醫療的許多重要的未滿足需求的可能性。

本報告提供全球醫療部門3D列印的市場調查,尤其以3D生物印刷與3D印刷醫藥品製造為焦點,提供產業及技術概要,法律制度,市場規模、成長預測,成本分析,主要交易,案例研究,價值鏈 、主要企業簡介等資訊。

目錄

第2章 參與企業

第3章 產業趨勢

  • 醫療保健部門趨勢
  • 技術趨勢
  • 宏觀經濟趨勢
  • 法規趨勢
  • 3D列印:醫療保健對產業的影響

第4章 產業分析

  • 市場規模、成長預測
  • 技術成本:各類型
  • 主要交易
  • 時間軸
  • 案例研究

第5章 價值鏈

  • 3D生物印刷
    • 硬體設備
    • 材料
  • 醫藥品3D列印

第6章 企業

  • 3D生物印刷企業
  • 3D列印企業

第7章 用語

第8章 附錄

目錄
Product Code: GDHCHT095

Three-dimensional (3D) printing is the process of joining materials to make objects from 3D model data, typically created by building one layer upon the previous layer. This contrasts with subtractive manufacturing, in which parts of a block of material are selectively removed. 3D printing is used across a range of sectors, including industry, electrical, aerospace, automotive, consumer, and healthcare.

In healthcare, 3D bioprinting is used to create living human cells or tissue for use in regenerative medicine and tissue engineering. 3D printing is also used to manufacture precision and personalized pharmaceuticals. Additionally, 3D printing technology is widely used in the manufacturing of medical devices, such as prosthetic limbs, orthopedic and dental implants, surgical instruments, and medical education models. The main focus of this report is 3D bioprinting and the manufacturing of 3D printed pharmaceuticals.

3D bioprinting of human tissue and cells has the potential to solve many critical unmet needs in healthcare, including regenerative medicine, functional organ replacement, and drug discovery. The growing aging population has driven the demand for donor organs, while regenerative medicine using bioprinted, patient-derived stem cells allows for personalized treatment of certain diseases. Use of bioprinted human tissue in drug discovery allows for quicker and more efficient processes, with better outcomes compared to using animal tissue. It also removes the need for animal testing, both in drug and cosmetic development. 3D printing of personalized drugs has the potential to revolutionize the pharmaceutical market. These drugs can be adapted to specific patient requirements, such as age, weight, and comorbidities. This ability to print therapies on demand not only has the potential to make medicine personal to patients, but would equally save millions in costs, resources, and, waste.

Recently, the rapid proliferation of COVID-19 has put an enormous strain on global healthcare systems, with demand for critical medical equipment and supplies mounting. The 3D printing community, from major manufacturers to start-ups and individuals, has responded to the COVID-19 crisis by pledging to support the production of vital medical equipment such as ventilators and personal protective equipment (PPE) for hospitals tackling the pandemic.

Scope

Components of the report include -

  • Key Industry Players - the leading companies in the 3D printing space in healthcare and where they sit in the value chain.
  • Industry Trends - key trends impacting the 3D Printing industry classified into healthcare, technology, macroeconomic, and regulatory themes.
  • Industry Analysis - market value of the entire 3D printing industry to 2025 and 2030, as well as key M&A, funding and partnerships in healthcare. There are also a number of case studies highlighting the different applications of 3D printing in healthcare, including how the 3D printing industry has rallied to provide medical equipment and supplies to healthcare systems fighting the current COVID-19 crisis.
  • Value Chain - Detailed overview of 3D bioprinting and 3D printing of pharmaceuticals by hardware and materials, including leading companies and challengers

Reasons to Buy

  • Develop business strategies by understanding how 3D printing is being used in the healthcare industry today and how the technology is expected to affect the healthcare sector in the future.
  • Stay up to date on the industry's big players in 3D printing and where they sit in the value chain.
  • Identify emerging industry trends to gain a competitive advantage.

Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Industry Players

3 Industry Trends

  • 3.1 Healthcare Trends
  • 3.2 Technology Trends
  • 3.3 Macroeconomic Trends
  • 3.4 Regulatory Trends
  • 3.5 Expected Impact of 3D Printing on the Healthcare Industry
    • 3.5.1 Impact on the Biopharmaceutical Industry
    • 3.5.2 Impact on the Medical Device Industry

4 Industry Analysis

  • 4.1 Market Size and Growth Forecasts
  • 4.2 Cost of Different Types of 3D Printing Technology
  • 4.3 Deals in 3D Printing in Healthcare
  • 4.4 Timeline of 3D Printing in Healthcare
  • 4.5 3D Printing in Healthcare Case Studies
    • 4.5.1 Use of 3D Printing in the Fight Against COVID-19
    • 4.5.2 3D Bioprinting and Regenerative Medicine
    • 4.5.3 Use of 3D Printing in Precision and Personalized Medicines
    • 4.5.4 Use of 3D Printing for Medical Education and Training

5 Value Chain

  • 5.1 3D Bioprinting
    • 5.1.1 3D Bioprinting Hardware
    • 5.1.2 3D Bioprinting Materials
  • 5.2 3D Printing of Pharmaceuticals

6 Companies

  • 6.1 3D Bioprinting Companies
  • 6.2 3D Printing Companies

7 Glossary

8 Appendix

  • 8.1 Bibliography
  • 8.2 Traditional Thematic Research Does a Poor Job of Picking Winners and Losers
  • 8.3 Introducing GlobalData's Thematic Engine
  • 8.4 This Is How It Works
  • 8.5 How Our Research Reports Fit into Our Overall Research Methodology
  • 8.6 About GlobalData
  • 8.7 About the Authors
    • 8.7.1 Healthcare Analyst
    • 8.7.2 Director of Thematic Analysis
    • 8.7.3 Senior Director of Market Research
    • 8.7.4 Global Head and EVP of Healthcare Operations and Strategy
  • 8.8 Contact Us
  • 8.9 Disclaimer

List of Tables

  • Table 1: Healthcare Trends
  • Table 2: Technology Trends
  • Table 3: Macroeconomic Trends
  • Table 4: Regulatory Trends
  • Table 5: M&As in the 3D Printing Industry
  • Table 6: Funding Activity in the 3D Printing Industry
  • Table 7: Partnerships in the 3D Printing Industry
  • Table 8: Examples of Top 3D Bioprinters
  • Table 9: 3D Bioprinting Companies
  • Table 10: 3D Printing Companies
  • Table 11: Glossary

List of Figures

  • Figure 1: Leaders and Challengers in 3D Printing in Healthcare
  • Figure 2: Pharma Executives Do Not Expect 3D Printing to Have a High Impact on the Industry in 2020
  • Figure 3: Pharma Technology Leaders Level of Understanding of 3D Printing Is Low
  • Figure 4: Pharma Technology Leaders View 3D Printing as an Important Future Technology
  • Figure 5: Pharma Technology Leaders Expect 3D Printing to Have a Positive Impact on the Industry
  • Figure 6: Business Readiness for the Impact of 3D Printing on the Medical Device Industry
  • Figure 7: Current and Future Business Usage of 3D Printing in the Medical Device Industry
  • Figure 8: Change in Business Spend on 3D Printing Over Time in the Medical Device Industry
  • Figure 9: Barriers to Adoption of 3D Printing in the Medical Device Industry
  • Figure 10: Business Action to Develop 3D Printing Expertise in the Medical Device Industry
  • Figure 11: Expected Impact of 3D Printing on Business Objectives Across the Medical Device Industry
  • Figure 12: Online 3D Printing Demand by Industry, 2018
  • Figure 13: Global 3D Printing Revenue to 2030 by Category
  • Figure 14: 3D Bioprinting is One of the Most Expensive 3D Printing Technologies
  • Figure 15: Timeline of 3D Printing in Healthcare
  • Figure 16: 3D Human Tissue Development Using Organovo's NovoGen 3D Bioprinter Platform
  • Figure 17: Biogelx Hydrogels Can Be Tailored to Match the Mechanical Properties of Specific Tissues
  • Figure 18: Cyfuse Biomedical's Proprietary Kenzan Method for 3D Bioprinting of Tissue
  • Figure 19: Cells Growing on Prellis Biologics' Organoid Basket Vascular Tissue Blank
  • Figure 20: Segmental Vitiligo on Left Eyebrow Before and Seven Months After Pigment Cell Transplant
  • Figure 21: 3D Bioprinting of Aspect Biosystem's Airway Smooth Muscle Tissue
  • Figure 22: Poietis' 4G Bioprinting NGB Platform
  • Figure 23: Aprecia Pharmaceutical's ZipDose Technology
  • Figure 24: FabRx's M3DIMAKER 3D Printer and Multiple Combination Pills
  • Figure 25: Case Examples of 3D Systems' VSP Orthopedics Offering
  • Figure 26: Axial3D's Aneurysm Model Used to Practice Procedure and Pre-select Equipment Before Surgery
  • Figure 27: The 3D Printing Industry Value Chain
  • Figure 28: 3D Bioprinting Process
  • Figure 29: 3D Bioprinting Hardware - Leaders and Challengers
  • Figure 30: 3D Bioprinting Materials - Leaders and Challengers
  • Figure 31: 3D Printing of Pharmaceuticals - Leaders and Challengers